We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Funko
FNKO
$328M
| $488K | ﹤0.01% |
22,932
-12,631
| -36% | -$287K |
|
2577
Blue Bird Corp
BLBD
$2.18B
| $487K | ﹤0.01% |
19,589
-1,800
| -8% | -$47.3K |
|
2578
Caesarstone
CSTE
$79.5M
| $487K | ﹤0.01% |
32,974
-3,637
| -10% | -$55K |
|
2579
Relmada Therapeutics
RLMD
$519M
| $485K | ﹤0.01% |
15,153
-1,240
| -8% | -$43.1K |
|
2580
Primis Financial Corp
FRST
$404M
| $483K | ﹤0.01% |
31,655
-1,728
| -5% | -$25.9K |
|
2581
Alignment Healthcare
ALHC
$2.98B
| $481K | ﹤0.01% |
+20,562
| New | +$500K |
|
2582
KRONOS Worldwide
KRO
$989M
| $479K | ﹤0.01% |
33,423
-5,964
| -15% | -$96.9K |
|
2583
Digimarc Corp
DMRC
$178M
| $478K | ﹤0.01% |
14,273
-1,377
| -9% | -$45.4K |
|
2584
Oportun Financial
OPRT
$372M
| $477K | ﹤0.01% |
23,797
-2,196
| -8% | -$45K |
|
2585
Quantum Corp
QMCO
$474M
| $476K | ﹤0.01% |
3,451
+1,418
| +70% | +$229K |
|
2586
Civista Bancshares
CIVB
$589M
| $475K | ﹤0.01% |
21,483
-3,491
| -14% | -$80.7K |
|
2587
Greif Class B
GEF.B
$4.21B
| $473K | ﹤0.01% |
8,013
-1,551
| -16% | -$93.5K |
|
2588
Bridgewater Bancshares
BWB
$603M
| $472K | ﹤0.01% |
29,232
-5,763
| -16% | -$96.5K |
|
2589
Aldeyra Therapeutics
ALDX
$93.5M
| $471K | ﹤0.01% |
+41,530
| New | +$499K |
|
|
CTO
2590
CTO Realty Growth
CTO
$815M
| $469K | ﹤0.01% |
26,286
-2,820
| -10% | -$49.9K |
|
2591
NN Inc
NNBR
$291M
| $469K | ﹤0.01% |
63,806
-6,273
| -9% | -$47.1K |
|
2592
Sana Biotechnology
SANA
$980M
| $469K | ﹤0.01% |
23,841
+2,860
| +14% | +$64.8K |
|
2593
RBB Bancorp
RBB
$455M
| $468K | ﹤0.01% |
19,323
-6,472
| -25% | -$145K |
|
2594
Immunovant
IMVT
$8.25B
| $467K | ﹤0.01% |
44,210
+2,252
| +5% | +$31.4K |
|
2595
Neurogene
NGNE
$712M
| $466K | ﹤0.01% |
2,523
+763
| +43% | +$169K |
|
|
CSTR
2596
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $466K | ﹤0.01% |
22,714
+810
| +4% | +$16.3K |
|
2597
Omega Flex
OFLX
$312M
| $465K | ﹤0.01% |
3,170
-280
| -8% | -$42.3K |
|
|
EBTC
2598
DELISTED
Enterprise Bancorp
EBTC
| $461K | ﹤0.01% |
14,069
-1,463
| -9% | -$49.9K |
|
2599
Frontier Group Holdings
ULCC
$1.7B
| $461K | ﹤0.01% |
+27,075
| New | +$534K |
|
|
GRTS
2600
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $459K | ﹤0.01% |
50,229
+13,837
| +38% | +$128K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.